Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950159-14-000491
Filing Date
2014-11-14
Accepted
2014-11-14 16:02:18
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 TENGION, INC. FORM 10-Q tengion10q.htm 10-Q 897783
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14149
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 13958
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6722
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6677
  Complete submission text file 0000950159-14-000491.txt   6719296

Data Files

Seq Description Document Type Size
6 tngn-20140930.xml EX-101.INS 1080428
7 tngn-20140930.xsd EX-101.SCH 46607
8 tngn-20140930_cal.xml EX-101.CAL 38390
9 tngn-20140930_def.xml EX-101.DEF 200104
10 tngn-20140930_lab.xml EX-101.LAB 620675
11 tngn-20140930_pre.xml EX-101.PRE 333162
Mailing Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103
Business Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103 336-722-5855
TENGION INC (Filer) CIK: 0001296391 (see all company filings)

EIN.: 200214813 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34688 | Film No.: 141223900
SIC: 2836 Biological Products, (No Diagnostic Substances)